Epstein David Rinsider trades
In SEC Form 4 filings, Epstein David R is listed as Director of AgomAb Therapeutics NV (AGMB) and Director of Tempus AI, Inc. (TEM). In the last 90 days, Epstein David R bought $219.7K of AgomAb Therapeutics NV (AGMB) and sold $16.4K of Tempus AI, Inc. (TEM) on the open market. The largest purchase was $44.5K of AgomAb Therapeutics NV (AGMB) on Oct 21. The sale was reported under a 10b5-1 trading plan. Took part in a cluster buy; the latest at AgomAb Therapeutics NV (AGMB), where 3 insiders bought within 4 days, ending Oct 8.
Companies and roles
Cluster buys
- AGMB: 3 insiders bought $311.2K between Oct 5 – Oct 8.
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| AGMBAgomAb Therapeutics NV | Oct 21 | Oct 22 | P | 5,000 | $8.86 | Purchase +$44,300 | 20,000 | No | Form 4 |
| AGMBAgomAb Therapeutics NV | Oct 21 | Oct 22 | P | 5,000 | $8.90 | Purchase +$44,500 | 25,000 | No | Form 4 |
| AGMBAgomAb Therapeutics NV | Oct 8 | Oct 9 | P | 5,000 | $8.90 | Purchase +$44,500 | 15,000 | No | Form 4 |
| AGMBAgomAb Therapeutics NV | Oct 6 | Oct 7 | P | 5,000 | $8.70 | Purchase +$43,500 | 10,000 | No | Form 4 |
| AGMBAgomAb Therapeutics NV | Oct 5 | Oct 7 | P | 5,000 | $8.57 | Purchase +$42,850 | 5,000 | No | Form 4 |
| TEMTempus AI, Inc. | Sep 1 | Sep 3 | S | 250 | $65.55 | Sale −$16,388 | 30,844 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.